Neurological disorders associated with deficiency of glutamate dehydrogenase
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Glutamate dehydrogenase (GDH) activity was measured in leukocytes from 88 patients with various types of degenerative neurological disorders affecting primarily the cerebellum and/or the basal ganglia, and 26 healthy control subjects. Twelve patients with slowly progressive multiple‐system atrophic disorders were found to have a partial deficiency of this enzyme (52% of control level). The majority of these patients evidenced a constellation of neurological findings consistent with the diagnosis of olivopontocerebellar atrophy, although others were atypical in their neurological manifestations. Thus, GDH‐deficient patients were encountered with predominantly extrapyramidal manifestations (atypical Parkinson's disease), cerebellar dysfunction with peripheral neuropathy, or anterior horn cell signs, suggesting that a pleomorphic phenotypic expression of the enzymatic deficiency may occur. Seven cases of GDH deficiency were familial and 5 were sporadic. The former patient group consisted of siblings of either sex, but no parents or offspring were affected. The genetic pattern of the disorder is compatible with autosomal recessive inheritance. Patients with dominantly inherited olivopontocerebellar atrophy or other types of cerebellar or basal ganglia degenerative neurological disorders showed normal GDH activity. Leukocyte GDH was fractionated into “particulate‐heat labile” and “soluble‐heat stable” components. In the patients the decrease in activity was limited to the “particulate‐heat labile” component. A genetic mutation of a GDH “isoenzyme” may occur in some patients with multiple‐system degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
A Flexible System of Enzymatic Analysis
(1972) · Elsevier eBooks · doi:10.1016/b978-0-12-457950-7.x5001-3 · Cited by 4,051
Handbook of clinical neurology
Servit, Z. (1975) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(75)90177-7 · Cited by 1,640
Walton, J. N. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90157-x · Cited by 964
THE OLIVOPONTOCEREBELLAR ATROPHIES: A REVIEW
KONIGSMARK, B. W., & WEINER, L. P. (1970) · Medicine · doi:10.1097/00005792-197005000-00003 · Cited by 264
Abnormal Glutamate Metabolism in an Adult-Onset Degenerative Neurological Disorder
Plaitakis, A., Berl, S., & Yahr, M. D. (1982) · Science · doi:10.1126/science.6121377 · Cited by 225
Self-citationThe Effect of Thyroxine on Isolated Dehydrogenases
Wolff, J. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81391-6 · Cited by 97
THE PURIFICATION AND PROPERTIES OF RAT BRAIN GLUTAMATE DEHYDROGENASE
Chee, P. Y., Dahl, J. L., & Fahien, L. A. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb11705.x · Cited by 79
Rosenhagen, H. (1943) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf01814853 · Cited by 36
Amyotrophy in multisystem genetic diseases.
Rosenberg, R. N. (1982) · PubMed · Cited by 13
Cited by
Glutamate and the pathophysiology of hypoxic–ischemic brain damage
Rothman, S. M., & Olney, J. W. (1986) · Annals of Neurology · doi:10.1002/ana.410190202 · Cited by 2,428
Excitotoxity and the NMDA receptor
Rothman, S. M., & Olney, J. W. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90177-9 · Cited by 1,058
Possible Therapeutic Applications of Antagonists of Excitatory Amino acid Neurotransmitters
Meldrum, B. (1985) · Clinical Science · doi:10.1042/cs0680113 · Cited by 550
Glutamate: its role in learning, memory, and the aging brain
McEntee, W. J., & Crook, T. H. (1993) · Psychopharmacology · doi:10.1007/bf02253527 · Cited by 403
Delayed neurotoxicity of excitatory amino acids In vitro
Rothman, S. M., Thurston, J. H., & Hauhart, R. E. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90347-2 · Cited by 330
Excitatory amino acids and neuropsychiatrie disorders
Olney, J. W. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90072-3 · Cited by 322
Abnormal glutamate metabolism in amyotrophic lateral sclerosis
Plaitakis, A., & Caroscio, J. T. (1987) · Annals of Neurology · doi:10.1002/ana.410220503 · Cited by 305
Self-citationAdeva, M. M., Souto, G., Blanco, N., & Donapetry, C. (2012) · Metabolism · doi:10.1016/j.metabol.2012.07.007 · Cited by 295
Szymocha, R., Akaoka, H., Dutuit, M., Malcus, C., Didier-Bazes, M., Belin, M.-F., & Giraudon, P. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6433-6441.2000 · Cited by 83
“pend on metabolic precursors provided by astrocytes (48) and are highly sensitive to excessive concentrations of extracellular glutamate (7, 37, 54).”
BackgroundShashidharan, P., & Plaitakis, A. (2014) · Neurochemical Research · doi:10.1007/s11064-013-1227-5 · Cited by 43
“Initial functional studies performed on recombinant hGDH1 and hGDH2 obtained by expression of the corresponding GLUD1 and GLUD2 cDNAs in Sf9 cells, revealed that while hGDH1 was heat-stable, hGDH2 was heat-labile [7], thus confirming our original observations suggesting that human GDH exists in two isoforms differing…”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Plaitakis, A., Berl, S., & Yahr, M. D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1984-02
- Volume
- 15
- Issue
- 2
- Pages
- 144-153
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2092094911
- Cited by
- 183
- References
- 10
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.